SEC Form 4 · accession 0001209191-16-094858
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troy Edward Wilson
Officer — President and CEO · Director
Period of report
Jan 29, 2016
Accepted (ET)
Feb 2, 2016 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $4.80 | Jan 29, 2016 | A | 120,000 | A | — | Jan 28, 2026 | Common stock | 120,000 | 120,000 | D |
Explanation of responses
- F1This option vests in 48 equal monthly installments commencing on the grant date.